Schechter Investment Advisors LLC Has $1.62 Million Position in Danaher Co. (NYSE:DHR)

Schechter Investment Advisors LLC lessened its stake in Danaher Co. (NYSE:DHR) by 8.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,033 shares of the conglomerate’s stock after selling 633 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Danaher were worth $1,615,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. Howard Capital Management Group LLC boosted its holdings in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 48 shares during the last quarter. Princeton Global Asset Management LLC raised its position in Danaher by 360.0% during the third quarter. Princeton Global Asset Management LLC now owns 230 shares of the conglomerate’s stock worth $64,000 after acquiring an additional 180 shares in the last quarter. Clear Creek Financial Management LLC bought a new stake in Danaher during the third quarter worth $207,000. Pure Financial Advisors LLC bought a new stake in Danaher during the third quarter worth $202,000. Finally, Kanawha Capital Management LLC bought a new stake in Danaher during the third quarter worth $217,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Down 1.0 %

Danaher stock opened at $205.60 on Tuesday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The firm has a 50 day moving average price of $224.11 and a two-hundred day moving average price of $244.31. The firm has a market cap of $146.94 billion, a price-to-earnings ratio of 38.94, a PEG ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business posted $2.09 earnings per share. Equities analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 24.24%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on DHR shares. JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research report on Friday, December 13th. Wells Fargo & Company decreased their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Guggenheim began coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.